The article entitle "Individualize medicine from prewomb to tomb" (http://www.cell.com/cell/fulltext/S0092-8674%2814%2900204-9 ) explain the new term “precision medicine” as defined by “tailoring of medical treatment to the individual characteristics of each patient”. This require multiple layers of data: biosensors, scanners, electronic medical records, social media, and the various omics that include DNA sequence, transcriptome, proteome, metabolome, epigenome, microbiome, and exposome.
From the integrated personal omics profiling (iPOP) or “Snyderome,” we are focus on the use of a biosensor watch to passively collect data that could make diagnosis at the earliest possible time, avoiding any end-organ damage or use the panoromic information, coupled with biosensors that track air quality, pollution, forced expiratory volume, and other relevant physiologic metrics, could prove useful to prevent an attack.
Furthermore we have the BLOOD ON CONTINOUS SURVEILLANCE by using injectable nanosensors to detect a DNA, RNA, autoantibody, or protein signal and to wirelessly transmit the signal to the individual’s Smartphone. This are the microfluidic electrochemical detector for in vivo continuous monitoring (MEDIC) (http://stm.sciencemag.org/content/5/213/213ra165.short )
By taking the deidentified data from each individual, including panoromic, biosensors, social graph, treatment, and outcomes allows massive open online medical information (MOOM) repositories that could provide matching capability to approximate a newly diagnosed individual’s data as compared with all of those previously amalgamated.
Via Unesco Telemedicine